A bal pitvari fülcse perkután zárása nonvalvularis pitvarfibrillációban-nemzetközi és hazai tapasztalatok

Géza Fontos, P. Andréka, András Temesvári, Dóra Wéber, A. Szatmári

Research output: Article

1 Citation (Scopus)

Abstract

In patients with non-valvular atrial fibrillation, efficacy of stroke prevention with oral anticoagulant therapy has been proved. Despite their high risk for thromboembolic events, there are substantial numbers of patients who are not candidates for long-term oral anticoagulant therapy, therefore the interest in alternative treatment strategies are in focus these days. The most common place within the heart for thrombus formation in patients with non-valvular atrial fibrillation is the left atrial appendage. Two devices specifically designed for percutaneous left atrial appendage closure are currently available in Europe: the WATCHMAN LAA system (Atritech, Inc) and the AMPLATZER Cardiac Plug (AGA Medical Corporation). Although present trial results (PLAATO, PROTECT AF) suggest that LAA closure may be performed at acceptable safety and it may reduce the long-term stroke risk, available data are still very limited. At present these procedures may be an acceptable alternative in selected high-risk patients with non-valvular atrial fibrillation who are not or suboptimal candidates for oral anticoagulant therapy. On 28. January, 2010 we performed the first three successful percutaneous left atrial appendage closure procedures in Gottsegen György Hungarian Institute of Cardiology in Hungary.

Original languageHungarian
Pages (from-to)725-734
Number of pages10
JournalOrvosi Hetilap
Volume151
Issue number18
DOIs
Publication statusPublished - máj. 1 2010

Fingerprint

Atrial Appendage
Anticoagulants
Atrial Fibrillation
Stroke
Hungary
Therapeutics
Cardiology
Thrombosis
Safety
Equipment and Supplies

Keywords

  • Atrial fibrillation
  • Left atrial appendage
  • Stroke

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A bal pitvari fülcse perkután zárása nonvalvularis pitvarfibrillációban-nemzetközi és hazai tapasztalatok. / Fontos, Géza; Andréka, P.; Temesvári, András; Wéber, Dóra; Szatmári, A.

In: Orvosi Hetilap, Vol. 151, No. 18, 01.05.2010, p. 725-734.

Research output: Article

@article{39a9e7e59a1848c8bf8bf32201d661ea,
title = "A bal pitvari f{\"u}lcse perkut{\'a}n z{\'a}r{\'a}sa nonvalvularis pitvarfibrill{\'a}ci{\'o}ban-nemzetk{\"o}zi {\'e}s hazai tapasztalatok",
abstract = "In patients with non-valvular atrial fibrillation, efficacy of stroke prevention with oral anticoagulant therapy has been proved. Despite their high risk for thromboembolic events, there are substantial numbers of patients who are not candidates for long-term oral anticoagulant therapy, therefore the interest in alternative treatment strategies are in focus these days. The most common place within the heart for thrombus formation in patients with non-valvular atrial fibrillation is the left atrial appendage. Two devices specifically designed for percutaneous left atrial appendage closure are currently available in Europe: the WATCHMAN LAA system (Atritech, Inc) and the AMPLATZER Cardiac Plug (AGA Medical Corporation). Although present trial results (PLAATO, PROTECT AF) suggest that LAA closure may be performed at acceptable safety and it may reduce the long-term stroke risk, available data are still very limited. At present these procedures may be an acceptable alternative in selected high-risk patients with non-valvular atrial fibrillation who are not or suboptimal candidates for oral anticoagulant therapy. On 28. January, 2010 we performed the first three successful percutaneous left atrial appendage closure procedures in Gottsegen Gy{\"o}rgy Hungarian Institute of Cardiology in Hungary.",
keywords = "Atrial fibrillation, Left atrial appendage, Stroke",
author = "G{\'e}za Fontos and P. Andr{\'e}ka and Andr{\'a}s Temesv{\'a}ri and D{\'o}ra W{\'e}ber and A. Szatm{\'a}ri",
year = "2010",
month = "5",
day = "1",
doi = "10.1556/OH.2010.28870",
language = "Hungarian",
volume = "151",
pages = "725--734",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "18",

}

TY - JOUR

T1 - A bal pitvari fülcse perkután zárása nonvalvularis pitvarfibrillációban-nemzetközi és hazai tapasztalatok

AU - Fontos, Géza

AU - Andréka, P.

AU - Temesvári, András

AU - Wéber, Dóra

AU - Szatmári, A.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - In patients with non-valvular atrial fibrillation, efficacy of stroke prevention with oral anticoagulant therapy has been proved. Despite their high risk for thromboembolic events, there are substantial numbers of patients who are not candidates for long-term oral anticoagulant therapy, therefore the interest in alternative treatment strategies are in focus these days. The most common place within the heart for thrombus formation in patients with non-valvular atrial fibrillation is the left atrial appendage. Two devices specifically designed for percutaneous left atrial appendage closure are currently available in Europe: the WATCHMAN LAA system (Atritech, Inc) and the AMPLATZER Cardiac Plug (AGA Medical Corporation). Although present trial results (PLAATO, PROTECT AF) suggest that LAA closure may be performed at acceptable safety and it may reduce the long-term stroke risk, available data are still very limited. At present these procedures may be an acceptable alternative in selected high-risk patients with non-valvular atrial fibrillation who are not or suboptimal candidates for oral anticoagulant therapy. On 28. January, 2010 we performed the first three successful percutaneous left atrial appendage closure procedures in Gottsegen György Hungarian Institute of Cardiology in Hungary.

AB - In patients with non-valvular atrial fibrillation, efficacy of stroke prevention with oral anticoagulant therapy has been proved. Despite their high risk for thromboembolic events, there are substantial numbers of patients who are not candidates for long-term oral anticoagulant therapy, therefore the interest in alternative treatment strategies are in focus these days. The most common place within the heart for thrombus formation in patients with non-valvular atrial fibrillation is the left atrial appendage. Two devices specifically designed for percutaneous left atrial appendage closure are currently available in Europe: the WATCHMAN LAA system (Atritech, Inc) and the AMPLATZER Cardiac Plug (AGA Medical Corporation). Although present trial results (PLAATO, PROTECT AF) suggest that LAA closure may be performed at acceptable safety and it may reduce the long-term stroke risk, available data are still very limited. At present these procedures may be an acceptable alternative in selected high-risk patients with non-valvular atrial fibrillation who are not or suboptimal candidates for oral anticoagulant therapy. On 28. January, 2010 we performed the first three successful percutaneous left atrial appendage closure procedures in Gottsegen György Hungarian Institute of Cardiology in Hungary.

KW - Atrial fibrillation

KW - Left atrial appendage

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=77951641987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951641987&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28870

DO - 10.1556/OH.2010.28870

M3 - Article

C2 - 20409999

AN - SCOPUS:77951641987

VL - 151

SP - 725

EP - 734

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 18

ER -